Computer alert aims to boost cholesterol treatment in heart patients

NCT ID NCT05088759

Ongoing Disease control Sponsor: Brigham and Women's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an electronic alert in the medical record can help doctors prescribe better cholesterol-lowering medications for heart disease patients with high LDL. About 400 patients from a single hospital will be randomly assigned to have their doctor receive the alert or not. The goal is to see if the alert leads to more appropriate prescriptions and lower LDL levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: electronic alert-based decision support system
What this could lead to: If successful, this alert system could help more heart disease patients get the right cholesterol medication, potentially reducing their risk of future heart attacks or strokes.
What could go wrong: This is a small, single-center quality improvement study, not a large clinical trial. The alert may not change prescribing habits significantly, and results may not apply to other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASCVD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerotic cardiovascular disease hyperlipidemia hyperlipoproteinemia type V

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASCVD HYPERLIPEMIA, MIXED

Contacts and locations

Show contact details

Locations

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.